Cargando…

Common disease signatures from gene expression analysis in Huntington’s disease human blood and brain

BACKGROUND: Huntington’s disease (HD) is a devastating brain disorder with no effective treatment or cure available. The scarcity of brain tissue makes it hard to study changes in the brain and impossible to perform longitudinal studies. However, peripheral pathology in HD suggests that it is possib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mina, Eleni, van Roon-Mom, Willeke, Hettne, Kristina, van Zwet, Erik, Goeman, Jelle, Neri, Christian, A.C. ’t Hoen, Peter, Mons, Barend, Roos, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968014/ https://www.ncbi.nlm.nih.gov/pubmed/27476530 http://dx.doi.org/10.1186/s13023-016-0475-2

Ejemplares similares

Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood
por: Mastrokolias, Anastasios, et al.
Publicado: (2015)

Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples
por: Mastrokolias, Anastasios, et al.
Publicado: (2016)

Juvenile‐Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review
por: Bakels, Hannah S., et al.
Publicado: (2021)

Nanopublications for exposing experimental data in the life-sciences: a Huntington’s Disease case study
por: Mina, Eleni, et al.
Publicado: (2015)

The MID1 Protein: A Promising Therapeutic Target in Huntington’s Disease
por: Heinz, Annika, et al.
Publicado: (2021)

Making (anti-) sense out of huntingtin levels in Huntington disease
por: Evers, Melvin M, et al.
Publicado: (2015)

Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease
por: Hensman Moss, Davina J., et al.
Publicado: (2017)

Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
por: Ouwerkerk, Jasper, et al.
Publicado: (2023)

Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease
por: van Roon-Mom, Willeke MC, et al.
Publicado: (2008)

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset
por: Gardiner, Sarah L., et al.
Publicado: (2018)

Pathological characterization of T2*-weighted MRI contrast in the striatum of Huntington’s disease patients
por: Bulk, Marjolein, et al.
Publicado: (2020)

Statistical method for modeling sequencing data from different technologies in longitudinal studies with application to Huntington disease
por: Fuady, Angga M., et al.
Publicado: (2020)

Post‐mortem 7T MR imaging and neuropathology in middle stage juvenile‐onset Huntington disease: A case report
por: Bakels, Hannah S., et al.
Publicado: (2022)

Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA
por: Mastrokolias, Anastasios, et al.
Publicado: (2012)

The dynamics of early-state transcriptional changes and aggregate formation in a Huntington’s disease cell model
por: van Hagen, Martijn, et al.
Publicado: (2017)

Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model
por: Toonen, Lodewijk J. A., et al.
Publicado: (2018)

Co-expression Patterns between ATN1 and ATXN2 Coincide with Brain Regions Affected in Huntington’s Disease
por: Keo, Arlin, et al.
Publicado: (2017)

GLUT-1 changes in paediatric Huntington disease brain cortex and fibroblasts: an observational case-control study
por: Tramutola, Antonella, et al.
Publicado: (2023)

Simultaneous Enrichment Analysis of all Possible Gene-sets: Unifying Self-Contained and Competitive Methods
por: Ebrahimpoor, Mitra, et al.
Publicado: (2019)

Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates
por: Schut, Menno H., et al.
Publicado: (2017)

Huntington's disease: a clinical review
por: Roos, Raymund AC
Publicado: (2010)

The Implicitome: A Resource for Rationalizing Gene-Disease Associations
por: Hettne, Kristina M., et al.
Publicado: (2016)

Aspiration pneumonia and death in Huntington’s disease
por: Heemskerk, Anne-Wil, et al.
Publicado: (2012)

Literature-aided meta-analysis of microarray data: a compendium study on muscle development and disease
por: Jelier, Rob, et al.
Publicado: (2008)

Exploring the Transcriptome of Ciliated Cells Using In Silico Dissection of Human Tissues
por: Ivliev, Alexander E., et al.
Publicado: (2012)

Cystathionine Levels in Patients With Huntington Disease
por: Aziz, N.A., et al.
Publicado: (2015)

A common gene expression signature in Huntington’s disease patient brain regions
por: Neueder, Andreas, et al.
Publicado: (2014)

Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
por: Evers, Melvin M., et al.
Publicado: (2013)

Preparing n-of-1 Antisense Oligonucleotide Treatments for Rare Neurological Diseases in Europe: Genetic, Regulatory, and Ethical Perspectives
por: Synofzik, Matthis, et al.
Publicado: (2022)

Progression of motor subtypes in Huntington’s disease: a 6-year follow-up study
por: Jacobs, M., et al.
Publicado: (2016)

Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
por: Toonen, Lodewijk J.A., et al.
Publicado: (2017)

Early grey matter changes in structural covariance networks in Huntington's disease
por: Coppen, Emma M., et al.
Publicado: (2016)

Disease Onset in Huntington's Disease: When Is the Conversion?
por: Oosterloo, Mayke, et al.
Publicado: (2021)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
por: Jurgens, Caroline K, et al.
Publicado: (2010)

Brain Transcriptomic Analysis of Hereditary Cerebral Hemorrhage With Amyloidosis-Dutch Type
por: Grand Moursel, Laure, et al.
Publicado: (2018)

Reduced functional brain connectivity prior to and after disease onset in Huntington's disease()()
por: Dumas, Eve M., et al.
Publicado: (2013)

Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study
por: Odish, Omar F.F., et al.
Publicado: (2015)

Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3
por: Toonen, Lodewijk J. A., et al.
Publicado: (2016)

Natriuretic Peptides in Post-mortem Brain Tissue and Cerebrospinal Fluid of Non-demented Humans and Alzheimer’s Disease Patients
por: Mahinrad, Simin, et al.
Publicado: (2018)

Prioritization of novel ADPKD drug candidates from disease-stage specific gene expression profiles
por: Malas, Tareq B., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rmk3juvr21c49kn5rqv9l9n88l